CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Open-market sale 10% owner sold 330,706 shares at $15.30 ($5,059,802)
- 4 Open-market sale Director sold 330,706 shares at $15.30 ($5,059,802)
- 10-Q Report Quarterly Report
- 4 Option exercise Chief Scientific Officer acquired 17,446 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 4 Other acquisition Director acquired 998,382 shares (other)
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 282,804 shares (conversion)
- 4 Open-market buy Director bought 2,979,566 shares at $18.00 ($53,632,188)
- 4 Open-market buy 10% owner bought 555,555 shares at $18.00 ($9,999,990)
- 4 Conversion Chief Financial Officer acquired 3,534 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 3,534 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 555,555 shares at $18.00 ($9,999,990)
Page 21 of 24 · 464 filings